
Behind the AI in the Newsroom: The Washington Post’s Vineet Khosla
May 5, 2026 - 38:56
Radio and PodcastLive Radio & Podcasts
Julian Adams tried but didn’t succeed at retirement after a productive career as a medical chemist with several U.S. Food and Drug Association approvals of cancer-related treatments, including cell therapy for bone marro...
Training AI to Detect Disease: Stand Up To Cancer’s Julian Adams is an episode from Me, Myself, and AI by MIT Sloan Management Review. Julian Adams tried but didn’t succeed at retirement after a productive career as a medical chemist with s...
This episode belongs to Me, Myself, and AI.
Use the player on this page to stream the episode online.
Published Jun 11, 2025, 30:40 long, audio available.
Julian Adams tried but didn’t succeed at retirement after a productive career as a medical chemist with several U.S. Food and Drug Association approvals of cancer-related treatments, including cell therapy for bone marrow transplantation. Soon after, his participation in a Stand Up To Cancer advisory group led to his appointment as the nonprofit’s president and CEO. The research organization raises money to advance the diagnosis of numerous cancers. Given rapid technological advancements, our podcast hosts were eager to invite Julian on the show to share how Stand Up To Cancer uses artificial intelligence to aid in this pursuit. Read the episode transcript here. For more information on Stand Up To Cancer and how to donate to the organization, please visit this website. Guest bio Julian Adams, president and CEO of Stand Up To Cancer, is among the world’s foremost oncology researchers. He was previously CEO of biopharmaceutical company Gamida Cell and president of R&D at Infinity Pharmaceuticals, where he oversaw development of small molecule drugs to treat cancer. He has also held roles at Millennium Pharmaceuticals, Boehringer Ingelheim, LeukoSite, and ProScript. Adams’s recognitions include the 2012 Warren Alpert Foundation Prize for his role in the discovery and development of bortezomib, an anti-cancer drug; the 2012 C. Chester Stock Award Lectureship from Memorial Sloan Kettering Cancer Center; and the 2001 Ribbon of Hope Award for Velcade from the International Myeloma Foundation. He holds more than 40 patents and has authored more than 130 papers and book chapters. He received his bachelor’s degree and an honorary doctor of science degree from McGill University and his Ph.D. from MIT in synthetic organic chemistry. Me, Myself, and AI is a collaborative podcast from MIT Sloan Management Review and Boston Consulting Group and is hosted by Sam Ransbotham and Shervin Khodabandeh. Our engineer is David Lishansky, and the executive producer is Allison Ryder. Stay in touch with us by joining our LinkedIn group, AI for Leaders at mitsmr.com/AIforLeaders or by following Me, Myself, and AI on LinkedIn. We encourage you to rate and review our show. Your comments may be used in Me, Myself, and AI materials.
You can listen to Training AI to Detect Disease: Stand Up To Cancer’s Julian Adams online on Radio and Podcast. Open the player on this page to stream the available audio.
Training AI to Detect Disease: Stand Up To Cancer’s Julian Adams is an episode from Me, Myself, and AI by MIT Sloan Management Review.
This episode is 30:40 long.
This episode was published on Jun 11, 2025.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from Me, Myself, and AI when more episodes are available from the podcast feed.
You can listen to Training AI to Detect Disease: Stand Up To Cancer’s Julian Adams on this page when the episode audio is available from the podcast feed.
Training AI to Detect Disease: Stand Up To Cancer’s Julian Adams is from Me, Myself, and AI by MIT Sloan Management Review.
Published Jun 11, 2025 and 30:40 long